NEUROLOGICAL SYMPTOMS IN PHARMACOTHERAPY OF PSYCHOSES.
D000927:Anticonvulsants; D002746:Chlorpromazine; D004298:Dopamine; D005116:Extrapyramidal Tracts; D006801:Humans; D008996:Monoamine Oxidase Inhibitors; D009069:Movement Disorders; D009461:Neurologic Manifestations; D010640:Phenothiazines; D011600:Psychopharmacology; D011618:Psychotic Disorders; D014116:Toxicology; D014149:Tranquilizing Agents
D000927:Anticonvulsants; D008996:Monoamine Oxidase Inhibitors; D010640:Phenothiazines; D014149:Tranquilizing Agents; C031637:phenothiazine; D002746:Chlorpromazine; D004298:Dopamine
ANTICONVULSANTS; CHLORPROMAZINE; DOPAMINE; EXTRAPYRAMIDAL TRACTS; MONOAMINE OXIDASE INHIBITORS; MOVEMENT DISORDERS; NEUROLOGIC MANIFESTATIONS; PHENOTHIAZINES; PSYCHOPHARMACOLOGY; PSYCHOSES; REVIEW; TOXICOLOGIC REPORT; TRANQUILIZING AGENTS